Access & reimbursement

mRNA Flu Shots Are No Longer a Pandemic Experiment

MRD Testing Moves From Prognosis Toward Treatment Action

Colon Cancer Immunotherapy Moves Into the Adjuvant Access Test

Narcolepsy Treatment Starts Targeting the Cause

Optic Neuritis Moves Into the Neuroprotection Race

AstraZeneca’s Baxfendy opens a new front in uncontrolled hypertension, but monitoring will decide who benefits

India’s emergency price-cap rise for cisplatin and carboplatin exposes a blunt oncology truth

Huntington’s Gene Therapy Moves Back Toward the FDA Door

G7 Cancer Call and WHA Precision Medicine Resolution: A Moment to Turn Ambition Into Delivery
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
